Prostate Cancer Diagnosis Pathway: 2024 Update

Anwar Padhani

A. Padhani

Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospec…

Jason Hafron

Year in Review - Prostate Cancer

Oncology 2024 Year in Review

K. Tawagi

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

Advanced Prostate Cancer Consensus Conference (APCCC)

K. Fizazi

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

Advanced Prostate Cancer Therapy: Effective and Minimally Invasive

DrTalks

M. Hong

GU Podcast: 2024 Highlights From Practice-Changing Trials in Prostat…

OncoAlert

R. Eapen, D. Murphy

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

Update on Systemic Treatments for Metastatic Prostate Cancer

Emmanuel Seront

Erectile Dysfunction in Patients with Prostate Cancer and Metabolic …

DrTalks

R. Valenzuela

Evolving Strategies in First and Second-Line Treatment for mCRPC

International Urology Cancer Summit - IUCS

N. Agarwal

Understanding PSMA PET Scans in Prostate Cancer Diagnosis

GRACE

K. Jatwani, K. Tawagi, M. Kurian

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

Prostate Cancer 2024 Year in Review: Key Trial Insights Including PA…

OncoAlert

S. Gillessen

Deep Dive Review of Prostate Cancer Updates From ASCO® GU 2025

The View on GU | with Lalani & Wallis

A. A. Lalani, C. Wallis